Clinical Trial Update: Efficacy of 1540 Nanometer Erbium Glass Laser to Improve Benign Dermatofibromas [NA]

View source ↗

Summary

A completed clinical trial evaluated a 1540 nanometer Erbium Glass laser for improving benign dermatofibromas; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatofibroma of the Skin

Drugs mentioned

• Erbium Glass laser 1540 nm (erbium glass laser 1540 nm)

Snippet

Sponsor: University of Utah | Conditions: Dermatofibroma of Skin | NA | Status: COMPLETED | Results posted: 2021-06-23